02/04/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/4/2020. This three-page document informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel. This test is to be performed only using respiratory specimens collected from individuals who meet CDC criteria for 2019-nCoV testing. (PDF)
No hay comentarios:
Publicar un comentario